Ali Reza Keramati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ali Reza Keramati has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Arya Mani
Yale University School of Medicine
4 shared publications Rajvir Singh
4 shared publicationsHugh Calkins
Precision Medicine Center of Excellence for ARVC and Complex Ventricular Arrhythmias, Johns Hopkins University School of Medicine, Baltimore, MD (T.Z., F.R.A., J.C., A.K., S.M., R.B., H.C., H.T.).
3 shared publicationsJonathan Chrispin
Division of Cardiology, The Johns Hopkins University School of Medicine, 1800 Orleans St, Zayed 7125, Baltimore, MD 21287, United States
3 shared publicationsA. Mani
2 shared publicationsFabrizio R. Assis
Precision Medicine Center of Excellence for ARVC and Complex Ventricular Arrhythmias, Johns Hopkins University School of Medicine, Baltimore, MD (T.Z., F.R.A., J.C., A.K., S.M., R.B., H.C., H.T.).
2 shared publications
Latest Publications
- Open Access
- 15 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Genome sequencing unveils a regulatory landscape of platelet reactivity
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiology of myocardial infarction and stroke. To build upon prior GWAS, here we report on 16 loci identified through a whole genome sequencing (WGS) approach in 3,855 NHLBI Trans-Omics for Precision Medicine (TOPMed) participants deeply phenotyped for platelet aggregation. We identify the RGS18 locus, which encodes a myeloerythroid lineage-specific regulator of G-protein signaling that co-localizes with expression quantitative trait loci (eQTL) signatures for RGS18 expression in platelets. Gene-based approaches implicate the SVEP1 gene, a known contributor of coronary artery disease risk. Sentinel variants at RGS18 and PEAR1 are associated with thrombosis risk and increased gastrointestinal bleeding risk, respectively. Our WGS findings add to previously identified GWAS loci, provide insights regarding the mechanism(s) by which genetics may influence cardiovascular disease risk, and underscore the importance of rare variant and regulatory approaches to identifying loci contributing to complex phenotypes.
- 15 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Open AccessGenome sequencing unveils a regulatory landscape of platelet reactivity
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiology of myocardial infarction and stroke. To build upon prior GWAS, here we report on 16 loci identified through a whole genome sequencing (WGS) approach in 3,855 NHLBI Trans-Omics for Precision Medicine (TOPMed) participants deeply phenotyped for platelet aggregation. We identify the RGS18 locus, which encodes a myeloerythroid lineage-specific regulator of G-protein signaling that co-localizes with expression quantitative trait loci (eQTL) signatures for RGS18 expression in platelets. Gene-based approaches implicate the SVEP1 gene, a known contributor of coronary artery disease risk. Sentinel variants at RGS18 and PEAR1 are associated with thrombosis risk and increased gastrointestinal bleeding risk, respectively. Our WGS findings add to previously identified GWAS loci, provide insights regarding the mechanism(s) by which genetics may influence cardiovascular disease risk, and underscore the importance of rare variant and regulatory approaches to identifying loci contributing to complex phenotypes.
- Open Access
- 28 February 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-12
Genome-wide association and multi-omic analyses reveal ACTN2 as a gene linked to heart failure
Heart failure is a major public health problem affecting over 23 million people worldwide. In this study, we present the results of a large scale meta-analysis of heart failure GWAS and replication in a comparable sized cohort to identify one known and two novel loci associated with heart failure. Heart failure sub-phenotyping shows that a new locus in chromosome 1 is associated with left ventricular adverse remodeling and clinical heart failure, in response to different initial cardiac muscle insults. Functional characterization and fine-mapping of that locus reveal a putative causal variant in a cardiac muscle specific regulatory region activated during cardiomyocyte differentiation that binds to the ACTN2 gene, a crucial structural protein inside the cardiac sarcolemma (Hi-C interaction p-value = 0.00002). Genome-editing in human embryonic stem cell-derived cardiomyocytes confirms the influence of the identified regulatory region in the expression of ACTN2. Our findings extend our understanding of biological mechanisms underlying heart failure.
- 28 February 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-12
Open AccessGenome-wide association and multi-omic analyses reveal ACTN2 as a gene linked to heart failure
Heart failure is a major public health problem affecting over 23 million people worldwide. In this study, we present the results of a large scale meta-analysis of heart failure GWAS and replication in a comparable sized cohort to identify one known and two novel loci associated with heart failure. Heart failure sub-phenotyping shows that a new locus in chromosome 1 is associated with left ventricular adverse remodeling and clinical heart failure, in response to different initial cardiac muscle insults. Functional characterization and fine-mapping of that locus reveal a putative causal variant in a cardiac muscle specific regulatory region activated during cardiomyocyte differentiation that binds to the ACTN2 gene, a crucial structural protein inside the cardiac sarcolemma (Hi-C interaction p-value = 0.00002). Genome-editing in human embryonic stem cell-derived cardiomyocytes confirms the influence of the identified regulatory region in the expression of ACTN2. Our findings extend our understanding of biological mechanisms underlying heart failure.
- 9 September 2019
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 30 (11) , 2627-2628
Persistent atrial fibrillation; It is time to regroup
Pulmonary vein isolation (PVI) is the only proven ablation strategy for paroxysmal and persistent atrial fibrillation (AF). However, when AF recurs despite durable PVI in a subgroup of patients with persistent AF, there is no scientifically proven ablation strategy to pursue. Here, we summarized how we approach persistent AF at Johns Hopkins Hospital.
- 9 September 2019
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 30 (11) , 2627-2628
Persistent atrial fibrillation; It is time to regroup
Pulmonary vein isolation (PVI) is the only proven ablation strategy for paroxysmal and persistent atrial fibrillation (AF). However, when AF recurs despite durable PVI in a subgroup of patients with persistent AF, there is no scientifically proven ablation strategy to pursue. Here, we summarized how we approach persistent AF at Johns Hopkins Hospital.
- 1 September 2018
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 11 (9) , e007546
Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
Background: Arrhythmogenic right ventricular cardiomyopathy is an inherited cardiomyopathy characterized by fibrofatty replacement of right ventricular myocardium resulting in reentrant ventricular tachycardia (VT). Cardiac magnetic resonance imaging (CMR) can noninvasively measure regional abnormalities using tissue-tracking strain as well as late gadolinium enhancement (LGE). In this study, we examine arrhythmogenic substrate using regional CMR strain, LGE, and electroanatomic mapping (EAM) in arrhythmogenic right ventricular cardiomyopathy patients presenting for VT ablation. Methods and Results: Twenty-one patients underwent right ventricular endocardial EAM, whereas 17 underwent epicardial EAM, to detect dense scar (P P =0.001), and at VT culprit sites (−7.4±3.7 versus −10.1±4.1; P P <0.05 for all). LGE and EAM demonstrated poor agreement with κ=0.18 (endocardial, n=17) and κ=0.06 (epicardial, n=13). Only 8 (15%) VT termination sites exhibited LGE. Conclusions: Regional myocardial strain on cine CMR improves detection of arrhythmogenic VT substrate compared with LGE. This may enhance diagnostic accuracy of CMR in arrhythmogenic right ventricular cardiomyopathy without the need for invasive procedures and facilitate the planning of VT ablation procedures.
- 1 September 2018
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 11 (9) , e007546
Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
Background: Arrhythmogenic right ventricular cardiomyopathy is an inherited cardiomyopathy characterized by fibrofatty replacement of right ventricular myocardium resulting in reentrant ventricular tachycardia (VT). Cardiac magnetic resonance imaging (CMR) can noninvasively measure regional abnormalities using tissue-tracking strain as well as late gadolinium enhancement (LGE). In this study, we examine arrhythmogenic substrate using regional CMR strain, LGE, and electroanatomic mapping (EAM) in arrhythmogenic right ventricular cardiomyopathy patients presenting for VT ablation. Methods and Results: Twenty-one patients underwent right ventricular endocardial EAM, whereas 17 underwent epicardial EAM, to detect dense scar (P P =0.001), and at VT culprit sites (−7.4±3.7 versus −10.1±4.1; P P <0.05 for all). LGE and EAM demonstrated poor agreement with κ=0.18 (endocardial, n=17) and κ=0.06 (epicardial, n=13). Only 8 (15%) VT termination sites exhibited LGE. Conclusions: Regional myocardial strain on cine CMR improves detection of arrhythmogenic VT substrate compared with LGE. This may enhance diagnostic accuracy of CMR in arrhythmogenic right ventricular cardiomyopathy without the need for invasive procedures and facilitate the planning of VT ablation procedures.
- 1 September 2018
- Published by Elsevier in Journal of Electrocardiology
- Vol. 51 (5) , 801-808
Initial validation of a novel ECGI system for localization of premature ventricular contractions and ventricular tachycardia in structurally normal and abnormal hearts
- 1 September 2018
- Published by Elsevier in Journal of Electrocardiology
- Vol. 51 (5) , 801-808
Initial validation of a novel ECGI system for localization of premature ventricular contractions and ventricular tachycardia in structurally normal and abnormal hearts
- 16 January 2018
- Published by Wolters Kluwer Health in Circulation
- Vol. 137 (3) , 307-309
Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention
Fentanyl is a potent opiate commonly administered during cardiac catheterization procedures in North America. The question of whether fentanyl could have adverse consequences in patients undergoing percutaneous coronary intervention (PCI) is raised by recent research demonstrating that intravenous morphine significantly delays the absorption of oral P2Y12 platelet inhibitors. The presumed mechanism is slowed gastric emptying. The single-center Platelet Aggregation with tiCagrelor Inhibition and FentanYl (PACIFY) trial randomized adults undergoing clinically-indicated elective coronary angiography to receive the procedure with or without intravenous fentanyl (NCT02683707). The study was approved by the Johns Hopkins Medicine Institutional Review Board and all participants provided written informed consent. Eligible adults had not received P2Y12 inhibitors for 14 days prior to enrollment. Other exclusion criteria included: pre-procedural treatment with oral anticoagulants or opiates; platelet count <100,000/mm(3); and impaired renal or hepatic function. All participants received subcutaneous lidocaine and intravenous midazolam at the start of the catheterization procedure and as needed thereafter. Doses of all drugs were at the discretion of treating providers. Patients and outcomes assessors were blinded, treating providers were not. Participants who required PCI received an oral dose of 180 mg of ticagrelor at the conclusion of diagnostic angiography.
- 16 January 2018
- Published by Wolters Kluwer Health in Circulation
- Vol. 137 (3) , 307-309
Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention
Fentanyl is a potent opiate commonly administered during cardiac catheterization procedures in North America. The question of whether fentanyl could have adverse consequences in patients undergoing percutaneous coronary intervention (PCI) is raised by recent research demonstrating that intravenous morphine significantly delays the absorption of oral P2Y12 platelet inhibitors. The presumed mechanism is slowed gastric emptying. The single-center Platelet Aggregation with tiCagrelor Inhibition and FentanYl (PACIFY) trial randomized adults undergoing clinically-indicated elective coronary angiography to receive the procedure with or without intravenous fentanyl (NCT02683707). The study was approved by the Johns Hopkins Medicine Institutional Review Board and all participants provided written informed consent. Eligible adults had not received P2Y12 inhibitors for 14 days prior to enrollment. Other exclusion criteria included: pre-procedural treatment with oral anticoagulants or opiates; platelet count <100,000/mm(3); and impaired renal or hepatic function. All participants received subcutaneous lidocaine and intravenous midazolam at the start of the catheterization procedure and as needed thereafter. Doses of all drugs were at the discretion of treating providers. Patients and outcomes assessors were blinded, treating providers were not. Participants who required PCI received an oral dose of 180 mg of ticagrelor at the conclusion of diagnostic angiography.
- 1 January 2018
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 4 (1) , 59-68
Multimodal Examination of Atrial Fibrillation Substrate
- 1 January 2018
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 4 (1) , 59-68
Multimodal Examination of Atrial Fibrillation Substrate
- 20 July 2017
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 28 (10) , 1189-1195
Anterior pericardial access to facilitate electrophysiology study and catheter ablation of ventricular arrhythmias: A single tertiary center experience
Introduction: Epicardial ablation is becoming an important part of management in patients with ventricular tachycardia (VT). Posterior epicardial access via the Sosa or needle‐in‐needle (NIN) approach for epicardial VT ablation is considered to be the method of choice for most electrophysiologists. Anterior epicardial access as an alternative technique has recently been proposed, but there are limited data about its safety, efficacy, and the rate of immediate complications. In this study, we report our experience with anterior epicardial access between 2009 and 2016.Methods: Between 2009 and June 2016, 100 consecutive patients underwent epicardial VT ablation using an anterior approach. The success rate, epicardial bleeding, and other complications related to the epicardial access in these patients were compared to the previously reported rate of complications in patients whom epicardial access was performed using the NIN or Sosa techniques.Results: Anterior epicardial access was obtained successfully in 100% of patients in the first attempt. The success rate of the anterior approach was comparable with the reported success rate of the NIN technique (100% vs. 100%, P value not significant) but better than the Sosa technique (100% vs. 94%, P = 0.012). None of the patients in the anterior approach series suffered from significant pericardial bleeding (defined as greater than 80 mL of blood loss), RV puncture/damage, or need for an emergent cardiac surgery.Conclusion: An anterior epicardial approach is feasible and appears to have an acceptable safety profile in comparison with other epicardial approaches.
- 20 July 2017
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 28 (10) , 1189-1195
Anterior pericardial access to facilitate electrophysiology study and catheter ablation of ventricular arrhythmias: A single tertiary center experience
Introduction: Epicardial ablation is becoming an important part of management in patients with ventricular tachycardia (VT). Posterior epicardial access via the Sosa or needle‐in‐needle (NIN) approach for epicardial VT ablation is considered to be the method of choice for most electrophysiologists. Anterior epicardial access as an alternative technique has recently been proposed, but there are limited data about its safety, efficacy, and the rate of immediate complications. In this study, we report our experience with anterior epicardial access between 2009 and 2016.Methods: Between 2009 and June 2016, 100 consecutive patients underwent epicardial VT ablation using an anterior approach. The success rate, epicardial bleeding, and other complications related to the epicardial access in these patients were compared to the previously reported rate of complications in patients whom epicardial access was performed using the NIN or Sosa techniques.Results: Anterior epicardial access was obtained successfully in 100% of patients in the first attempt. The success rate of the anterior approach was comparable with the reported success rate of the NIN technique (100% vs. 100%, P value not significant) but better than the Sosa technique (100% vs. 94%, P = 0.012). None of the patients in the anterior approach series suffered from significant pericardial bleeding (defined as greater than 80 mL of blood loss), RV puncture/damage, or need for an emergent cardiac surgery.Conclusion: An anterior epicardial approach is feasible and appears to have an acceptable safety profile in comparison with other epicardial approaches.
- Open Access
- 2 February 2016
- Published by Wolters Kluwer Health in Circulation
- Vol. 133 (5)
Type B Dissection in a Pregnant Woman Managed With Peripartum Thoracic Endovascular Aortic Repair
- 2 February 2016
- Published by Wolters Kluwer Health in Circulation
- Vol. 133 (5)
Open AccessType B Dissection in a Pregnant Woman Managed With Peripartum Thoracic Endovascular Aortic Repair
- 1 July 2015
- Published by Elsevier in Atherosclerosis
- Vol. 241 (1) , e23
DYRK1B modifies insulin action in liver and skeletal muscle and predispose to atherosclerosis
- 1 July 2015
- Published by Elsevier in Atherosclerosis
- Vol. 241 (1) , e23
DYRK1B modifies insulin action in liver and skeletal muscle and predispose to atherosclerosis